AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
THE IMMUNOMODULATOR AS101 INHIBITS IL-10 RELEASE AND AUGMENTS TNF-ALPHA AND IL-1-ALPHA RELEASE BY MOUSE AND HUMAN MONONUCLEAR PHAGOCYTES
Authors: SREDNI B STRASSMANN G
Citation: B. Sredni et G. Strassmann, THE IMMUNOMODULATOR AS101 INHIBITS IL-10 RELEASE AND AUGMENTS TNF-ALPHA AND IL-1-ALPHA RELEASE BY MOUSE AND HUMAN MONONUCLEAR PHAGOCYTES, European cytokine network, 9(3), 1998, pp. 449-449
HYDROGEN-PEROXIDE RELEASED BY NEUTROPHILS AUGMENTS THE SECRETION OF MACROPHAGE TNF-ALPHA
Authors: SREDNIKENIGSBUCH D KAMBAYASHI T STRASSMANN G
Citation: D. Srednikenigsbuch et al., HYDROGEN-PEROXIDE RELEASED BY NEUTROPHILS AUGMENTS THE SECRETION OF MACROPHAGE TNF-ALPHA, European cytokine network, 9(3), 1998, pp. 452-452
UP-REGULATION BY AMMONIUM TRICHLORO(DIOXOETHYLENE-0,0')TELLURATE (AS101) OF FAS APO-1 EXPRESSION ON B16 MELANOMA-CELLS - IMPLICATIONS FOR THE ANTITUMOR EFFECTS OF AS101/
Authors: KALECHMAN Y STRASSMANN G ALBECK M SREDNI B
Citation: Y. Kalechman et al., UP-REGULATION BY AMMONIUM TRICHLORO(DIOXOETHYLENE-0,0')TELLURATE (AS101) OF FAS APO-1 EXPRESSION ON B16 MELANOMA-CELLS - IMPLICATIONS FOR THE ANTITUMOR EFFECTS OF AS101/, The Journal of immunology (1950), 161(7), 1998, pp. 3536-3542
THE IMMUNOMODULATOR AS101 RESTORES T-H1 TYPE OF RESPONSE SUPPRESSED BY BABESIA-RODHAINI IN BALB C MICE/
Authors: ROSENBLATTBIN H KALECHMAN Y VONSOVER A XU RH DA JP SHALIT F HUBERMAN M KLEIN A STRASSMANN G ALBECK M SREDNI B
Citation: H. Rosenblattbin et al., THE IMMUNOMODULATOR AS101 RESTORES T-H1 TYPE OF RESPONSE SUPPRESSED BY BABESIA-RODHAINI IN BALB C MICE/, Cellular immunology (Print), 184(1), 1998, pp. 12-25
SYNERGISTIC EFFECT BETWEEN IL-10 AND BCL-2 GENOTYPES IN DETERMINING SUSCEPTIBILITY TO SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: MEHRIAN R QUISMORIO FP STRASSMANN G STIMMLER MM HORWITZ DA KITRIDOU RC GAUDERMAN WJ MORRISON J BRAUTBAR C JACOB CO
Citation: R. Mehrian et al., SYNERGISTIC EFFECT BETWEEN IL-10 AND BCL-2 GENOTYPES IN DETERMINING SUSCEPTIBILITY TO SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(4), 1998, pp. 596-602
RADIOTHERAPY OF TENNIS ELBOW
Authors: HEYD R SCHOPOHL B KIRCHNER J STRASSMANN G BOTTCHER HD
Citation: R. Heyd et al., RADIOTHERAPY OF TENNIS ELBOW, Deutsche Medizinische Wochenschrift, 122(9), 1997, pp. 247-252
VESNARINONE INHIBITS IMMUNE-MEDIATED BUT NOT FAS (CD95) AGONIST-MEDIATED HEPATIC-INJURY
Authors: LAZARUS DD KAMBAYASHI T YATOKIOKA M BAUMANN H JACOB CO STRASSMANN G
Citation: Dd. Lazarus et al., VESNARINONE INHIBITS IMMUNE-MEDIATED BUT NOT FAS (CD95) AGONIST-MEDIATED HEPATIC-INJURY, International journal of immunopharmacology, 19(1), 1997, pp. 49
PROTECTIVE EFFECT OF THE PHOSPHODIESTERASE INHIBITOR ROLIPRAM AN EXPERIMENTAL AUTOIMMUNE UVEORETINITIS (EAU)
Authors: XU H STRASSMANN G CHAN CC SILVER PB WIGGERT B CASPI RR
Citation: H. Xu et al., PROTECTIVE EFFECT OF THE PHOSPHODIESTERASE INHIBITOR ROLIPRAM AN EXPERIMENTAL AUTOIMMUNE UVEORETINITIS (EAU), Investigative ophthalmology & visual science, 38(4), 1997, pp. 2073-2073
SIMULTANEOUS PACLITAXEL AND RADIOTHERAPY - INITIAL CLINICAL-EXPERIENCE IN LUNG-CANCER AND OTHER MALIGNANCIES
Authors: VOGT HG MARTIN T KOLOTAS C SCHNEIDER L STRASSMANN G ZAMBOGLOU N
Citation: Hg. Vogt et al., SIMULTANEOUS PACLITAXEL AND RADIOTHERAPY - INITIAL CLINICAL-EXPERIENCE IN LUNG-CANCER AND OTHER MALIGNANCIES, Seminars in oncology, 24(4), 1997, pp. 101-105
THE IMMUNOMODULATOR AS-101 INHIBITS IL-10 RELEASE AND AUGMENTS TNF-ALPHA AND IL-1-ALPHA RELEASE BY MOUSE AND HUMAN MONONUCLEAR PHAGOCYTES
Authors: STRASSMANN G KAMBAYASHI T JACOB CO SREDNI D
Citation: G. Strassmann et al., THE IMMUNOMODULATOR AS-101 INHIBITS IL-10 RELEASE AND AUGMENTS TNF-ALPHA AND IL-1-ALPHA RELEASE BY MOUSE AND HUMAN MONONUCLEAR PHAGOCYTES, Cellular immunology, 176(2), 1997, pp. 180-185
SYNERGISTIC EFFECT BETWEEN IL-10 AND BCL-2 GENOTYPES IN DETERMINING SUSCEPTIBILITY TO SLE
Authors: MEHRIAN R QUISMORIO FP STRASSMANN G STIMMLER MM HORWITZ DH KITRIDOU RC GAUDERMAN WJ MORRISON J BRAUTBAR C JACOB CO
Citation: R. Mehrian et al., SYNERGISTIC EFFECT BETWEEN IL-10 AND BCL-2 GENOTYPES IN DETERMINING SUSCEPTIBILITY TO SLE, Arthritis and rheumatism, 40(9), 1997, pp. 1710-1710
PREDOMINANCE OF TH1 RESPONSE IN TUMOR-BEARING MICE AND CANCER-PATIENTS TREATED WITH AS101
Authors: SREDNI B TICHLER T SHANI A CATANE R KAUFMAN B STRASSMANN G ALBECK M KALECHMAN Y
Citation: B. Sredni et al., PREDOMINANCE OF TH1 RESPONSE IN TUMOR-BEARING MICE AND CANCER-PATIENTS TREATED WITH AS101, Journal of the National Cancer Institute, 88(18), 1996, pp. 1276-1284
MACROPHAGE-DERIVED TUMOR-NECROSIS-FACTOR AND TUMOR-DERIVED OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 - POSSIBLE CELLULAR MECHANISMS OF CANCER CACHEXIA
Authors: BILLINGSLEY KG FRAKER DL STRASSMANN G LOESER C FLIOT HM ALEXANDER HR
Citation: Kg. Billingsley et al., MACROPHAGE-DERIVED TUMOR-NECROSIS-FACTOR AND TUMOR-DERIVED OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 - POSSIBLE CELLULAR MECHANISMS OF CANCER CACHEXIA, Annals of surgical oncology, 3(1), 1996, pp. 29-35
IR-192 ENDOVASCULAR BRACHYTHERAPY FOR AVOIDANCE OF INTIMAL HYPERPLASIA AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENT IMPLANTATION IN PERIPHERAL VESSELS - 6 YEARS OF EXPERIENCE
Authors: SCHOPOHL B LIERMANN D POHLIT LJ HEYD R STRASSMANN G BAUERSACHS R SCHULTEHUERMANN D RAHL CG MANEGOLD KH KOLLATH J BOTTCHER HD
Citation: B. Schopohl et al., IR-192 ENDOVASCULAR BRACHYTHERAPY FOR AVOIDANCE OF INTIMAL HYPERPLASIA AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENT IMPLANTATION IN PERIPHERAL VESSELS - 6 YEARS OF EXPERIENCE, International journal of radiation oncology, biology, physics, 36(4), 1996, pp. 835-840
THE LACK OF AN EFFECT BY INSULIN OR INSULIN-LIKE GROWTH-FACTOR-I IN ATTENUATING COLON-26-MEDIATED CANCER CACHEXIA
Authors: LAZARUS DD KAMBAYASHI T LOWRY SF STRASSMANN G
Citation: Dd. Lazarus et al., THE LACK OF AN EFFECT BY INSULIN OR INSULIN-LIKE GROWTH-FACTOR-I IN ATTENUATING COLON-26-MEDIATED CANCER CACHEXIA, Cancer letters, 103(1), 1996, pp. 71-77
VESNARINONE IS A SELECTIVE INHIBITOR OF MACROPHAGE TNF-ALPHA RELEASE
Authors: KAMBAYASHI T MAZUREK N JACOB CO WEI N FONG M STRASSMANN G
Citation: T. Kambayashi et al., VESNARINONE IS A SELECTIVE INHIBITOR OF MACROPHAGE TNF-ALPHA RELEASE, International journal of immunopharmacology, 18(6-7), 1996, pp. 371-378
INFLUENCE ON PATIENTS MANAGEMENT BY WHOLE-BODY F-18 FDG PET FOR PREOPERATIVE STAGING OF NON-SMALL-CELL LUNG-CANCER
Authors: BAUM RP RUST M ADAMS S STRASSMANN G BERKEFELD J WAGNER R HERTEL A HOR G
Citation: Rp. Baum et al., INFLUENCE ON PATIENTS MANAGEMENT BY WHOLE-BODY F-18 FDG PET FOR PREOPERATIVE STAGING OF NON-SMALL-CELL LUNG-CANCER, The Journal of nuclear medicine, 37(5), 1996, pp. 473-473
MUTATIONAL ANALYSIS OF TNF-ALPHA GENE REVEALS A REGULATORY ROLE FOR THE 3'-UNTRANSLATED REGION IN THE GENETIC PREDISPOSITION TO LUPUS-LIKE AUTOIMMUNE-DISEASE
Authors: JACOB CO LEE SK STRASSMANN G
Citation: Co. Jacob et al., MUTATIONAL ANALYSIS OF TNF-ALPHA GENE REVEALS A REGULATORY ROLE FOR THE 3'-UNTRANSLATED REGION IN THE GENETIC PREDISPOSITION TO LUPUS-LIKE AUTOIMMUNE-DISEASE, The Journal of immunology, 156(8), 1996, pp. 3043-3050
IL-4 AND IL-13 MODULATE IL-10 RELEASE IN ENDOTOXIN-STIMULATED MURINE PERITONEAL MONONUCLEAR PHAGOCYTES
Authors: KAMBAYASHI T JACOB CO STRASSMANN G
Citation: T. Kambayashi et al., IL-4 AND IL-13 MODULATE IL-10 RELEASE IN ENDOTOXIN-STIMULATED MURINE PERITONEAL MONONUCLEAR PHAGOCYTES, Cellular immunology, 171(1), 1996, pp. 153-158
INHIBITION OF EXPERIMENTAL CANCER CACHEXIA BY ANTI-CYTOKINE AND ANTI-CYTOKINE-RECEPTOR THERAPY
Authors: STRASSMANN G KAMBAYASHI T
Citation: G. Strassmann et T. Kambayashi, INHIBITION OF EXPERIMENTAL CANCER CACHEXIA BY ANTI-CYTOKINE AND ANTI-CYTOKINE-RECEPTOR THERAPY, Cytokines and molecular therapy, 1(2), 1995, pp. 107-113
TLD-MEASUREMENTS OF THE INCREASE OF SURFACE DOSE DUE TO WOUND DRESSINGS DURING PERCUTANEOUS IRRADIATION
Authors: THILMANN C ADAMIETZ IA RAMM U RAHN R STRASSMANN G MOSE S SARAN F BOTTCHER HD
Citation: C. Thilmann et al., TLD-MEASUREMENTS OF THE INCREASE OF SURFACE DOSE DUE TO WOUND DRESSINGS DURING PERCUTANEOUS IRRADIATION, European journal of cancer, 31A, 1995, pp. 190-190
INSULIN OR INSULIN-LIKE GROWTH-FACTOR-I DO NOT ATTENUATE THE CACHEXIAIN COLON-26 (C-26) CANCER
Authors: LAZARUS DD KAMBAYASHI T LOWRY SF STRASSMANN G
Citation: Dd. Lazarus et al., INSULIN OR INSULIN-LIKE GROWTH-FACTOR-I DO NOT ATTENUATE THE CACHEXIAIN COLON-26 (C-26) CANCER, The FASEB journal, 9(3), 1995, pp. 223-223
ROLE OF SURAMIN AS AN IL-1 INHIBITOR IN SUPPRESSION OF ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION
Authors: ESTROV Z TALPAZ M ESTEY EH STRASSMANN G
Citation: Z. Estrov et al., ROLE OF SURAMIN AS AN IL-1 INHIBITOR IN SUPPRESSION OF ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION, Experimental hematology, 23(10), 1995, pp. 1080-1087
SURAMIN TREATMENT SUPPRESSES INDUCTION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS (EAU) IN RODENTS
Authors: SARTANI G SILVER PB STRASSMANN G CHAN CC CASPI RR
Citation: G. Sartani et al., SURAMIN TREATMENT SUPPRESSES INDUCTION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS (EAU) IN RODENTS, Current eye research, 14(10), 1995, pp. 887-896
EFFECT OF LIPOSOME-MEDIATED MACROPHAGE DEPLETION ON LPS-INDUCED CYTOKINE GENE-EXPRESSION AND RADIOPROTECTION
Authors: SALKOWSKI CA NETA R WYNN TA STRASSMANN G VANROOIJEN N VOGEL SN
Citation: Ca. Salkowski et al., EFFECT OF LIPOSOME-MEDIATED MACROPHAGE DEPLETION ON LPS-INDUCED CYTOKINE GENE-EXPRESSION AND RADIOPROTECTION, The Journal of immunology, 155(6), 1995, pp. 3168-3179
Risultati: 1-25 | 26-42